Patents by Inventor Rebecca L. McCloud

Rebecca L. McCloud has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230121082
    Abstract: The present disclosure provides azetidine compounds of Formula I and their pharmaceutically acceptable salts, their compositions, and methods for their use in determining azetidine compound binding to proteins. The azetidine compounds are useful as probes, for monitoring diacylglycerol kinase activity, and for identifying druggable targets.
    Type: Application
    Filed: October 12, 2022
    Publication date: April 20, 2023
    Inventors: Ku-Lung Hsu, Rebecca L. McCloud
  • Patent number: 11512072
    Abstract: The present disclosure provides azetidine compounds of Formula I and their pharmaceutically acceptable salts, their compositions, and methods for their use in determining azetidine compound binding to proteins. The azetidine compounds are useful as probes, for monitoring diacylglycerol kinase activity, and for identifying druggable targets.
    Type: Grant
    Filed: April 19, 2019
    Date of Patent: November 29, 2022
    Assignee: University of Virginia Patent Foundation
    Inventors: Ku-Lung Hsu, Rebecca L. McCloud
  • Publication number: 20210101884
    Abstract: The present disclosure provides azetidine compounds of Formula I and their pharmaceutically acceptable salts, their compositions, and methods for their use in determining azetidine compound binding to proteins. The azetidine compounds are useful as probes, for monitoring diacylglycerol kinase activity, and for identifying druggable targets.
    Type: Application
    Filed: April 19, 2019
    Publication date: April 8, 2021
    Inventors: Ku-Lung Hsu, Rebecca L. McCloud